Cardiology

Medtronic Announces First Human Use of Its Bifurcation Stent

Published in Law and Health Weekly, March 15th, 2008

Seeking to address a challenge facing interventional cardiologists and hundreds of thousands of patients with coronary artery disease worldwide, Medtronic, Inc. (NYSE: MDT), announced the first human use of its investigational bifurcation stent. The new stent employs an innovative Y-shaped design to match the anatomy of lesions that form at the junctions of coronary arteries.

Dr. Robert Whitbourn, associate professor and director of the Cardiovascular Research Centre at St. Vincent's Hospital in Melbourne, performed the first clinical implant of the new device on Feb. 25 as an investigator in the trial, dubbed the BRANCH study. "I left the first case very encouraged by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2008-03-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry